Found 11 matching trials
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes PHASE2 This is a randomized, double-blind, placebo-controlled parallel group study...
Show More Location
AdventHealth Translational Research Institute
Learn More & Join Trial
Phase 1, Open-Label, Randomized, Study of the Safety and Pharmacokinetics of HU6 PHASE1 This is a five-part study being conducted to evaluate the safety, tolerabil...
Show More Learn More & Join Trial
A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6 PHASE1 This is a single-center, non-randomized, open-label Phase 1 study to charac...
Show More Location
Pharmaron Clinical Pharmacology Center (CPC)
Learn More & Join Trial
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis PHASE2 This is a phase 2 randomized, double-blind, placebo-controlled parallel gro...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Multiple Ascending Dose Study of HU6 in High BMI Volunteers PHASE1 This is a 14-day multiple ascending dose trial in high BMI volunteers in up...
Show More Location
Prism Clinical Research
Learn More & Join Trial
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) PHASE2 Rivus Pharmaceuticals. Inc. is sponsoring this research study to assess the...
Show More Location
Arizona Liver Health - Chandler
Learn More & Join Trial
Safety and Pharmacokinetics of HU6 PHASE1 Part 1 is an open-label, randomized, Latin-square 2x2 crossover study. Twel...
Show More Learn More & Join Trial
Ascending Dose Study of HU6 in Healthy Volunteers PHASE1 This is a single ascending dose trial in healthy volunteers. The study will...
Show More Location
Prism Clinical Research
Learn More & Join Trial
Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF PHASE2 This is a Phase 2A, randomized, parallel-group, placebo-controlled, double-...
Show More Location
National Heart Institute
Learn More & Join Trial
Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers PHASE2 This is a Phase 2a, randomized, parallel-group, placebo-controlled, double-...
Show More Location
Prism Clinical Research
Learn More & Join Trial